112 related articles for article (PubMed ID: 19269221)
1. Genetic analysis of ryanodine receptor 1 gene and carnitine palmitoyltransferase II gene: an autopsy case of neuroleptic malignant syndrome related to vegetamin.
Matsusue A; Hara K; Kageura M; Kashiwagi M; Lu W; Ishigami A; Gotohda T; Tokunaga I; Nisimura A; Sugimura T; Kubo S
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S570-2. PubMed ID: 19269221
[TBL] [Abstract][Full Text] [Related]
2. An autopsy case of rhabdomyolysis related to vegetamin and genetic analysis of the rhabdomyolysis-associated genes.
Matsusue A; Hara K; Kageura M; Kashiwagi M; Lu W; Ishigami A; Gotohda T; Tokunaga I; Nisimura A; Sugimura T; Kubo S
J Forensic Leg Med; 2010 Jan; 17(1):46-9. PubMed ID: 20083051
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of the rhabdomyolysis-associated genes in forensic autopsy cases of methamphetamine abusers.
Matsusue A; Hara K; Kashiwagi M; Kageura M; Sugimura T; Kubo S
Leg Med (Tokyo); 2011 Jan; 13(1):7-11. PubMed ID: 20952238
[TBL] [Abstract][Full Text] [Related]
4. Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome.
Sato T; Nishio H; Iwata M; Kentotsuboi ; Tamura A; Miyazaki T; Suzuki K
Forensic Sci Int; 2010 Jan; 194(1-3):77-9. PubMed ID: 19931341
[TBL] [Abstract][Full Text] [Related]
5. [A case of neuroleptic malignant syndrome with acute renal failure].
Shiono A; Hayashi M; Yamanaka H; Yajima H; Koya J
Hinyokika Kiyo; 1992 Nov; 38(11):1249-52. PubMed ID: 1485575
[TBL] [Abstract][Full Text] [Related]
6. Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF.
Kaneoka H; Uesugi N; Moriguchi A; Hirose S; Takayanagi M; Yamaguchi S; Shigematsu Y; Yasuno T; Sasatomi Y; Saito T
Am J Kidney Dis; 2005 Mar; 45(3):596-602. PubMed ID: 15754283
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
Hogan KJ; Vladutiu GD
Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel mutation V2321M of the cardiac ryanodine receptor gene of sudden unexplained death and a phenotypic study of the gene mutations.
Nishio H; Iwata M; Tamura A; Miyazaki T; Tsuboi K; Suzuki K
Leg Med (Tokyo); 2008 Jul; 10(4):196-200. PubMed ID: 18262818
[TBL] [Abstract][Full Text] [Related]
10. Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Russell T; Riazi S; Kraeva N; Steel AC; Hawryluck LA
Anaesthesia; 2012 Sep; 67(9):1021-4. PubMed ID: 22734812
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.
Martín MA; Rubio JC; del Hoyo P; García A; Bustos F; Campos Y; Cabello A; Culebras JM; Arenas J
Hum Mutat; 2000 Jun; 15(6):579-80. PubMed ID: 10862092
[TBL] [Abstract][Full Text] [Related]
12. [Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy].
Imoberdorf R; Krähenbühl S; Krapf R
Schweiz Med Wochenschr; 1998 Jun; 128(25):1024-9. PubMed ID: 9691338
[TBL] [Abstract][Full Text] [Related]
13. Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature.
Nishio H; Sato T; Fukunishi S; Tamura A; Iwata M; Tsuboi K; Suzuki K
Leg Med (Tokyo); 2009 May; 11(3):142-3. PubMed ID: 19223216
[TBL] [Abstract][Full Text] [Related]
14. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency.
Isackson PJ; Bennett MJ; Vladutiu GD
Mol Genet Metab; 2006 Dec; 89(4):323-31. PubMed ID: 16996287
[TBL] [Abstract][Full Text] [Related]
15. Novel mutations associated with carnitine palmitoyltransferase II deficiency.
Taggart RT; Smail D; Apolito C; Vladutiu GD
Hum Mutat; 1999; 13(3):210-20. PubMed ID: 10090476
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency.
Kottlors M; Jaksch M; Ketelsen UP; Weiner S; Glocker FX; Lücking CH
Neuromuscul Disord; 2001 Nov; 11(8):757-9. PubMed ID: 11595519
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
Corti S; Bordoni A; Ronchi D; Musumeci O; Aguennouz M; Toscano A; Lamperti C; Bresolin N; Comi GP
J Neurol Sci; 2008 Mar; 266(1-2):97-103. PubMed ID: 17936304
[TBL] [Abstract][Full Text] [Related]
18. [Myoglobinuria due to a deficiency of carnitine palmitoyltransferase II. A clinical case report].
Venturini E; Pupeschi L
Recenti Prog Med; 1994 May; 85(5):282-3. PubMed ID: 8023007
[TBL] [Abstract][Full Text] [Related]
19. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia.
Aleman M; Riehl J; Aldridge BM; Lecouteur RA; Stott JL; Pessah IN
Muscle Nerve; 2004 Sep; 30(3):356-65. PubMed ID: 15318347
[TBL] [Abstract][Full Text] [Related]
20. Myocardium and striated muscle damage caused by licit or illicit drugs.
Tóth AR; Varga T
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S484-7. PubMed ID: 19342269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
